Skip to main content

LI-COR Biosciences, BD Biosciences Market Infrared System for Pathway Analysis

NEW YORK, Jan. 29-LI-COR Biosciences and BD Biosciences will jointly market an infrared antibody-based imaging system for cell signaling pathway analysis, the two companies said today.

 

In the cooperative effort, BD's Pharmigen division will supply antibodies designed for use with LI-COR's Odyssey Infrared Imaging System.

 

BD Biosciences Pharmigen has a license to LI-COR's IRDye800CW, and will commercialize antibodies conjugated to this dye.

 

These two products will allow researchers interested in cell signaling to analyze more than one target molecule at a time. LI-COR says that its infrared imaging system can detect and quantify as little as one picogram of protein in Western blots.

 

LI-COR, which makes infrared labeling systems for sequencing, genotyping, and proteomics, is based in Lincoln, Neb. BD Biosciences is a  business division of Becton, Dickinson and Company.

For further information, see the press release.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.